Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 11, 2016 | Regentis Biomaterials | $15.0M Series D | Haisco Pharmaceutical Group | Generali, SCP Vitalife Partners, Technion Innovation Opportunities Fund, Technion Research and Development Foundation |
| May 14, 2012 | Regentis Biomaterials | $10.0M Series C | — | Crossroad Fund, Royal DSM, SCP Vitalife Partners, Technion |